In the biotech world, you can’t see everything
Earlier this week, I attended a screening of You Can See Everything, the buzzy new documentary about the disgraced former biotech CEO Elizabeth Holmes. I went in not really knowing what to expect. I’d avoided spoilers (and won’t be giving anything away here, either!). I was wondering what new information this film could reveal, given…
- 1. Elizabeth Holmes founded Theranos at 19, claiming it could perform over 100 diagnostic tests on a few drops of blood, raising hundreds of millions and achieving a $9 billion valuation.
- 2. Investigations in 2015 revealed Theranos's tests were unreliable, its device untested, and samples analyzed on third-party machines, leading to a $0 valuation by 2016 and fraud charges in 2018.
- 3. The article emphasizes the importance of peer-reviewed data in science and warns that even honest scientists can exaggerate, while also noting the rise of preprint servers that bypass traditional review.
Article analysis
Skim this article about "In the biotech world, you can’t see everything": 3 key takeaways and more.
In the biotech world, you can’t see everything
skim AI Analysis | MIT Technology Review
MIT Technology Review on In the biotech world, you can’t see everything: skim's analysis surfaces 3 key takeaways. The article reviews a documentary about Elizabeth Holmes and Theranos, reflecting on Holmes's manipulative nature and the ease with which appealing narratives can deceive. Read the takeaways in seconds, then decide whether the full article is worth your time.
Category: Opinion. News article analyzed by skim.
Summary
The article reviews a documentary about Elizabeth Holmes and Theranos, reflecting on Holmes's manipulative nature and the ease with which appealing narratives can deceive. It contrasts Holmes's claims with the historical lack of peer-reviewed data and the importance of scientific rigor, questioning whether even journalists can avoid falling for such deceptions.
Key Takeaways
- Elizabeth Holmes founded Theranos at 19, claiming it could perform over 100 diagnostic tests on a few drops of blood, raising hundreds of millions and achieving a $9 billion valuation.
- Investigations in 2015 revealed Theranos's tests were unreliable, its device untested, and samples analyzed on third-party machines, leading to a $0 valuation by 2016 and fraud charges in 2018.
- The article emphasizes the importance of peer-reviewed data in science and warns that even honest scientists can exaggerate, while also noting the rise of preprint servers that bypass traditional review.
Statement Breakdown
- Claimed Facts: 50% of statements the article presents as facts
- Opinions: 40% of statements classified as editorial or subjective
- Claims: 10% of statements surfaced for additional reader evaluation
Credibility & Bias Reasoning
Credibility assessment: The article relies on established facts about Theranos and Elizabeth Holmes, citing reputable sources like the Wall Street Journal and Forbes. However, it also incorporates the author's personal reflections and feelings about a documentary, which introduces a subjective element.
Bias assessment: Subjective Skepticism. The author expresses personal empathy for Holmes while simultaneously highlighting her manipulative nature and the historical evidence of her deception. This creates a nuanced but ultimately skeptical perspective on Holmes's potential for redemption or honesty.
Note: This article blends factual reporting on the Theranos case with the author's personal reactions to a documentary. Consider the author's subjective interpretations alongside the presented facts.
Credibility flag: Personal Reflection
Claimed Facts (8)
- This is a factual statement about Holmes's early life and the founding of Theranos.
- This presents financial figures and valuations related to Theranos as factual.
- This cites a specific publication and its assessment of Holmes's wealth.
- This details a specific event and the source of initial concerns about Theranos.
- This states a legal action taken against Theranos and its executives.
- This provides the outcome of legal proceedings against Holmes.
- This states a specific date for the commencement of her prison sentence.
- This identifies a specific issue that was an early indicator of problems at Theranos.
Opinions (8)
- This expresses the author's personal emotional response to a scene in the documentary.
- This is a subjective assessment of Holmes's character and abilities.
- This is an interpretation of Holmes's actions and their effect on another person.
- This describes the author's personal experience and feeling while watching the film.
- This is a speculative question posed by the author, reflecting personal doubt.
- This is a statement of self-perception and organizational pride regarding journalistic practices.
- This describes the author's personal journalistic methodology and standards.
- This is a personal reflection on the film's impact and a general observation about human susceptibility.
Claims (8)
- While plausible, the 'apparent bid' and the motivation are interpretations of Holmes's intentions, not definitively proven facts within the article.
- This is a rhetorical question expressing doubt about Holmes's ability to regain credibility, rather than a factual statement.
- While a quote, the context of Parloff's reflection is presented without further detail on his specific regrets or the extent of his 'blowing it,' making it a potentially loaded statement.
- This is a statement of personal belief and suspicion from Herper, not a proven fact of Holmes's deception in that specific interaction.
- This quote highlights Holmes's persuasive ability but also implies a level of self-deception or manipulation that is difficult to objectively quantify or prove as a consistent trait in every interaction.
- This is a broad, unqualified statement about the fallibility of scientific publications, presented without specific examples or context within the article.
- This is a generalization about scientists that, while likely true, is presented as a definitive statement without specific evidence in this context.
- This is a generalization about the behavior of some scientists, presented as a common occurrence without specific data.
Key Sources
- Jessica Hamzelou — Author
- Elizabeth Holmes — Founder of Theranos
- Forbes — Publication
- Wall Street Journal — Publication
- MIT Technology Review — Publication
- Ramesh Balwani — Former Company President
- Nathan Fielder — Filmmaker
- Lance Oppenheim — Filmmaker
- Billy Evans — Partner of Elizabeth Holmes
- Roger Parloff — Journalist
- Fortune — Publication
- Matthew Herper — Journalist
- STAT — Publication
- Tyler Shultz — Former Theranos Employee
This analysis was generated by skim (skim.plus), an AI-powered content analysis platform by Credible AI. Scores and classifications represent the platform's AI-generated assessment and should be considered alongside other sources.
skim analyzes recent MIT Technology Review coverage for what holds up, what reads as opinion, and what may not be fully supported. Last updated 23rd October 2026.